9th Circ. Rejects Rehearing On Norvir Antitrust Deal
A federal appeals court has rejected a bid for an en banc rehearing of its decision to limit a settlement to $10 million in a class action alleging that Abbott Laboratories...To view the full article, register now.
Already a subscriber? Click here to view full article